NCT00192842View on ClinicalTrials.gov

Gemcitabine With Curcumin for Pancreatic Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

17

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

November 30, 2007

Study Completion Date

September 30, 2010

Conditions

Pancreatic Cancer

Interventions

DRUG

curcumin (+ gemcitabine)

All Listed Sponsors

lead

Rambam Health Care Campus

OTHER

NCT00192842 - Gemcitabine With Curcumin for Pancreatic Cancer | Biotech Hunter | Biotech Hunter